Journal of the American Academy of Dermatology
Volume 64, Issue 6 , Pages 1159-1163.e2 , June 2011

Palmar fasciitis and polyarthritis syndrome associated with transitional cell carcinoma of the bladder

  • Lynsey L. Clarke, BM, MRCP

      Affiliations

    • University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
    • Corresponding Author InformationReprint requests: Dr Lynsey L Clarke, Academic Rheumatology Unit, The Courtyard, Bristol Royal Infirmary, BS2 8HW.
    • ,
  • Cameron T.C. Kennedy, FRCP

      Affiliations

    • University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
    • ,
  • Peter Hollingworth, FRCP

      Affiliations

    • North Bristol NHS Trust, Bristol, United Kingdom

References 

  1. Olivieri I, Salvarani C, Cantini F, Olivieri I, Salvarani C, Cantini F. RS3PE syndrome: an overview. Clin Exp Rheumatol. 2000;18:S53–S55
  2. Grobner T, Prischl FC, Grobner T, Prischl FC. Gadolinium and nephrogenic systemic fibrosis. Kidney Int. 2007;72:260–264
  3. Foti R, Leonardi R, Rondinone R, Di Gangi M, Leonetti C, Canova M, et al. Scleroderma-like disorders. Autoimmun Rev. 2008;7:331–339
  4. Medsger TA, Dixon JA, Garwood VF, Medsger TA, Dixon JA, Garwood VF. Palmar fasciitis and polyarthritis associated with ovarian carcinoma. Ann Intern Med. 1982;96:424–431
  5. Baron M, Baron M. Palmar fasciitis, polyarthritis, and carcinoma. Ann Intern Med. 1982;97:616
  6. Taggart AJ, Iveson JM, Wright V, Taggart AJ, Iveson JM, Wright V. Shoulder-hand syndrome and symmetrical arthralgia in patients with tubo-ovarian carcinoma. Ann Rheum Dis. 1984;43:391–393
  7. Shiel WC, Prete PE, Jason M, Andrews BS, Shiel WC, Prete PE, et al. Palmar fasciitis and arthritis with ovarian and non-ovarian carcinomas. New syndrome. Am J Med. 1985;79:640–644
  8. McGill PE, Calman KC, McGill PE, Calman KC. Shoulder-hand syndrome in patients with ovarian carcinoma. Ann Rheum Dis. 1985;44:72
  9. Strobel ES, Lacour M, Peter HH, Strobel ES, Lacour M, Peter HH. Palmar fascial thickening and contractures of fingers resembling arthritis—a paraneoplastic symptom?. Rheumatol Int. 1992;12:79–80
  10. Vinker S, Dgani R, Lifschitz-Mercer B, Sthoeger ZM, Green L, Vinker S, et al. Palmar fasciitis and polyarthritis associated with ovarian carcinoma in a young patient. A case report and review of the literature. Clin Rheumatol. 1996;15:495–497
  11. Wright GD, Doherty M, Wright GD, Doherty M. Unusual and memorable. Paraneoplastic palmar fasciitis and arthritis syndrome. Ann Rheum Dis. 1997;56:626
  12. Matteson EL. Groove sign in paraneoplastic palmar fasciitis. J Rheumatol. 1998;25:2043–2045
  13. Alexandroff AB, Hazleman BL, Matthewson M, Black CM, Rytina E, Crawford R, et al. Woody hands. Lancet. 2003;361:1344
  14. Denschlag D, Riener E, Vaith P, Tempfer C, Keck C, Denschlag D, et al. Palmar fasciitis and polyarthritis as a paraneoplastic syndrome associated with tubal carcinoma: a case report. Ann Rheum Dis. 2004;63:1177–1178
  15. Martorell EA, Murray PM, Peterson JJ, Menke DM, Calamia KT, Martorell EA, et al. Palmar fasciitis and arthritis syndrome associated with metastatic ovarian carcinoma: a report of four cases. J Hand Surg [Am]. 2004;29:654–660
  16. Giannakopoulos CK, Kyriakidou GK, Toufexi GE, Giannakopoulos CK, Kyriakidou GK, Toufexi GE. Palmar fasciitis and polyarthritis associated with secondary ovarian carcinoma. Case report. Eur J Gynaecol Oncol. 2005;26:339–341
  17. Yogarajah M, Soh J, Lord B, Goddard N, Stratton R, Yogarajah M, et al. Palmar fasciitis and polyarthritis syndrome: a sign of ovarian malignancy. J R Soc Med. 2008;101:473–475
  18. Baer AN, Phillips RM, Baer AN, Phillips RM. Pancreatic carcinoma and palmar fasciitis. Ann Intern Med. 1983;99:411–412
  19. Michaels RM, Sorber JA, Michaels RM, Sorber JA. Reflex sympathetic dystrophy as a probable paraneoplastic syndrome: case report and literature review. Arthritis Rheum. 1984;27:1183–1185
  20. Goldberg E, Dobransky R, Gill R, Goldberg E, Dobransky R, Gill R. Reflex sympathetic dystrophy associated with malignancy. Arthritis Rheum. 1985;28:1079–1080
  21. Pfinsgraff J, Buckingham RB, Killian PJ, Keister SR, Brereton WF, Weinblatt ME, et al. Palmar fasciitis and arthritis with malignant neoplasms: a paraneoplastic syndrome. Semin Arthritis Rheum. 1986;16:118–125
  22. Valverde-Garcia J, Juanola-Roura X, Ruiz-Martin JM, Nolla-Sole JM, Rodriguez-Moreno J, Roig-Escofet D, et al. Paraneoplastic palmar fasciitis-polyarthritis syndrome associated with breast cancer. J Rheumatol. 1987;14:1207–1209
  23. Caron P, Lassoued S, Thibaut I, Fournie B, Fournie A, Caron P, et al. Thyroid plasmacytoma with dermatomyositis and palmar fasciitis. J Rheumatol. 1989;16:997–999
  24. Van den Bergh L, Vanneste SB, Knockaert DC, Van den Bergh L, Vanneste SB, Knockaert DC. Palmar fasciitis and arthritis associated with cancer of the prostate. Acta Clin Belg. 1991;46:106–110
  25. Willemse PH, Mulder NH, van de Tempel HJ, Aalders JG, Sleijfer DT. Palmar fasciitis and arthritis in a patient with an extraovarian adenocarcinoma of the coelomic epithelium. Ann Rheum Dis. 1991;50:53–54
  26. Zerbe S, Blickle JF, Willemin B, Madon M, Brogard JM. Palmar fasciitis, a paraneoplastic manifestation: a new case. Eur J Intern Med. 1991;2:51–53
  27. Leslie BM. Palmar fasciitis and polyarthritis associated with a malignant neoplasm: a paraneoplastic syndrome. Orthopedics. 1992;15:1436–1439
  28. Dhote R, Beuzeboc P, Permal S, Poiraudeau S, Revel M, Christoforov B, et al. Paraneoplastic palmar fasciitis and achalasia-like esophageal disorder in a patient with breast cancer. Rev Rheum Engl Ed. 1997;64:350–352
  29. Saxman SB, Seitz D, Saxman SB, Seitz D. Breast cancer associated with palmar fasciitis and arthritis. J Clin Oncol. 1997;15:3515–3516
  30. Eekhoff EM, van der Lubbe PA, Breedveld FC, Eekhoff EM, van der Lubbe PA, Breedveld FC. Flexion contractures associated with a malignant neoplasm: ‘A paraneoplastic syndrome?’. Clin Rheumatol. 1998;17:157–159
  31. Grados F, Houvenagel E, Cayrolle G, Bellony R, Fardellone P, Sebert JL, et al. Two new cancer locations accompanied with palmar fasciitis and polyarthritis. Rev Rheum Engl Ed. 1998;65:212–214
  32. Enomoto M, Takemura H, Suzuki M, Yuhara T, Akama T, Yamane K, et al. Palmar fasciitis and polyarthritis associated with gastric carcinoma: complete resolution after total gastrectomy. [see comment]. Intern Med. 2000;39:754–757
  33. Kase H, Aoki Y, Sugaya S, Takakuwa K, Tanaka K. Palmar fasciitis and polyarthritis associated with squamous cell carcinoma of the cervix. Int J Gynecol Cancer. 2000;10:507–509
  34. Docquier C, Majois F, Mitine C, Docquier C, Majois F, Mitine C. Palmar fasciitis and arthritis: association with endometrial adenocarcinoma. Clin Rheumatol. 2002;21:63–65
  35. Virik K, Lynch KP, Harper P, Virik K, Lynch KP, Harper P. Gastroesophageal cancer, palmar fasciitis and a matrix metalloproteinase inhibitor. Intern Med. 2002;32:50–51
  36. Rammeh N, Elleuch M, Meddeb N, Sahli H, Cheour E, Sellami S, et al. [Palmar-plantar fasciitis and multiple myeloma]. Tunisie Med. 2003;81:889–893French
  37. Sheehy C, Ryan JG, Kelly M, Barry M, Sheehy C, Ryan JG, et al. Palmar fasciitis and polyarthritis syndrome associated with non-small-cell lung carcinoma. Clin Rheumatol. 2007;26:1951–1953
  38. Haroon M, Phelan M, Haroon M, Phelan M. A paraneoplastic case of palmar fasciitis and polyarthritis syndrome. Nat Clin Pract Rheumatol. 2008;4:274–277
  39. Champion GD, Saxon JA, Kossard S, Champion GD, Saxon JA, Kossard S. The syndrome of palmar fibromatosis (fasciitis) and polyarthritis. J Rheumatol. 1987;14:1196–1198
  40. Fernandez-Nebro A, Fernandez-Ruiz A, Rodriguez M, Haro M, Rodriguez-Andreu J, Gonzalez-Santos P, et al. Palmar fasciitis and polyarthritis syndrome is multicausal. Clin Rheumatol. 1996;15:99–101
  41. Seaman JM, Goble M, Madsen L, Steigerwald JC, Seaman JM, Goble M, et al. Fasciitis and polyarthritis during antituberculous therapy. Arthritis Rheum. 1985;28:1179–1184
  42. Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol. 2002;14:681–685
  43. Prud'homme GJ. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest. 2007;87:1077–1091
  44. Denton CP, Abraham DJ, Denton CP, Abraham DJ. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol. 2001;13:505–511
  45. Leask A, Denton CP, Abraham DJ, Leask A, Denton CP, Abraham DJ. Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma. J Invest Dermatol. 2004;122:1–6
  46. Stratton R, Shiwen X, Martini G, Holmes A, Leask A, Haberberger T, et al. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J Clin Invest. 2001;108:241–250
  47. Blank N, Max R, Lorenz HM, Blank N, Max R, Lorenz HM. The role of DMARDs in systemic sclerosis therapy. Rheumatology (Oxford) 2006;45 Suppl. 3:iii42-4. Erratum in: Rheumatology (Oxford). 2008;(47):234–235
  48. Chung L, Lin J, Furst DE, Fiorentino D, Chung L, Lin J, et al. Systemic and localized scleroderma. Clin Dermatol. 2006;24:374–392
  49. Sapadin AN, Fleischmajer R, Sapadin AN, Fleischmajer R. Treatment of scleroderma. Arch Dermatol. 2002;138:99–105
  50. Morath C, Schwenger V, Beimler J, Mehrabi A, Schmidt J, Zeier M, et al. Antifibrotic actions of mycophenolic acid. Clin Transplant. 2006;20(Suppl17):25–29
  51. Roos N, Poulalhon N, Farge D, Madelaine I, Mauviel A, Verrecchia F, et al. In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil. J Pharmacol Exp Ther. 2007;321:583–589
  52. Gabrielli A, Svegliati S, Moroncini G, Luchetti M, Tonnini C, Avvedimento EV, et al. Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets. Autoimmun Rev. 2007;7:121–126
  53. Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med. 2006;354:2667–2676Comment in: N Engl J Med 2006;354:2709-11; 2006;355:1278-9; author reply 1279-1280
  54. Piccaluga PP, Paolini S, Martinelli G, Piccaluga PP, Paolini S, Martinelli G. Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Cancer. 2007;110:1178–1186
  55. Chung L, Fiorentino DF, Benbarak MJ, Adler AS, Mariano MM, Paniagua RT, et al. Molecular framework for response to imatinib mesylate in systemic sclerosis. Arthritis Rheum. 2009;60:584–591
  56. Distler JH, Distler O. Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis. Rheumatology (Oxford). 2008;47(Suppl 5):v10–V11
  57. Moreno-Romero JA, Fernandez-Aviles F, Carreras E, Rovira M, Martinez C, Mascaro JM, et al. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease. Arch Dermatol. 2008;144:1106–1109
  58. Akhmetshina A, Venalis P, Dees C, Busch N, Zwerina J, Schett G, et al. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Arthritis Rheum. 2009;60:219–224
  59. Tyndall A, Matucci-Cerinic M, Muller-Ladner U. Future targets in the management of systemic sclerosis. Rheumatology (Oxford). 2009;48:iii49–i53

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)02205-1

doi: 10.1016/j.jaad.2009.11.680

Journal of the American Academy of Dermatology
Volume 64, Issue 6 , Pages 1159-1163.e2 , June 2011

Article Tools

* Image Usage & Resolution